TCL Archive Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL June 11, 2014
TCL Archive ODAC Advice: Avoid ESAs In Curative Settings, Require Patients To Sign Informed Consent. March 14, 2008